These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1660814)

  • 1. Tolerance to anticonvulsant effects of the partial benzodiazepine receptor agonist abecarnil in kindled rats involves learning.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Pharmacol; 1991 Sep; 202(3):303-10. PubMed ID: 1660814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of chronic treatment with abecarnil to induce contigent and noncontingent tolerance in pentylenetetrazol-kindled rats.
    Serra M; Ghiani CA; Maciocco E; Pisu MG; Tuligi G; Porceddu ML; Giggio G
    Epilepsia; 1996 Apr; 37(4):332-5. PubMed ID: 8603637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
    Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
    J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of isoniazid-induced convulsions by abecarnil in mice tolerant to diazepam.
    Serra M; Ghiani CA; Motzo C; Porceddu ML; Biggio G
    Pharmacol Biochem Behav; 1995 Oct; 52(2):249-54. PubMed ID: 8577786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
    Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
    Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingent tolerance to carbamazepine: a peripheral-type benzodiazepine mechanism.
    Weiss SR; Post RM
    Eur J Pharmacol; 1991 Feb; 193(2):159-63. PubMed ID: 1646732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant tolerance to clonazepam in amygdala kindled rats: clonazepam concentrations and benzodiazepine receptor binding.
    Suzuki Y; Wang L; Edge J; Mimaki T; Walson PD
    Neuropharmacology; 1994 Jul; 33(7):869-74. PubMed ID: 7969807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tolerance to clobazam in fully kindled rats: effects of intermittent flumazenil administration.
    Löscher W; Rundfeldt C
    Eur J Pharmacol; 1990 May; 180(2-3):255-71. PubMed ID: 2114299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.
    Natolino F; Zanotti A; Contarino A; Lipartiti M; Giusti P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):612-7. PubMed ID: 8938660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
    Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
    J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant efficacy of clonazepam and the beta-carboline ZK 93423 during chronic treatment in amygdala-kindled rats.
    Löscher W; Hönack D; Hashem A
    Eur J Pharmacol; 1987 Nov; 143(3):403-14. PubMed ID: 3691663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of gamma-aminobutyric acidA receptor complex after the in vivo administration of the anxioselective and anticonvulsant beta-carboline derivative abecarnil.
    Serra M; Foddi MC; Ghiani CA; Melis MA; Motzo C; Concas A; Sanna E; Biggio G
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1360-8. PubMed ID: 1361574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abecarnil enhances recovery from diazepam tolerance.
    Zanotti A; Natolino F; Contarino A; Lipartiti M; Giusti P
    Neuropharmacology; 1999 Sep; 38(9):1281-8. PubMed ID: 10471081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective changes in the in vivo effects of benzodiazepine receptor ligands after chemical kindling with FG 7142.
    Little HJ; Nutt DJ; Taylor SC
    Neuropharmacology; 1987 Jan; 26(1):25-31. PubMed ID: 3031534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
    Löscher W; Hönack D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):452-60. PubMed ID: 1352384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs.
    Hönack D; Löscher W
    Epilepsia; 1995 Aug; 36(8):763-71. PubMed ID: 7635095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.
    De Sarro G; Di Paola ED; Gareri P; Gallelli L; Scotto G; De Sarro A
    Eur J Pharmacol; 1999 Mar; 368(2-3):149-59. PubMed ID: 10193651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.